Sort by
Keyphrases
Dyslipidemia
100%
Clinical Trials
100%
Triglycerides
100%
Hemoglobin A1c (HbA1c)
100%
Oxidized Low-density Lipoprotein (ox-LDL)
100%
In Vitro Antioxidant Activity
100%
Cardiometabolic Risk
100%
Phytochemicals
100%
Citrus Bergamia
100%
Cholesterol
50%
Clinical Efficacy
50%
Apolipoprotein B (Apo B)
50%
Cardiometabolic Disease
50%
LDL Cholesterol
50%
Body Mass
50%
Treatment-related Adverse Events
50%
Myeloperoxidase Activity
50%
Follow-up Cases
50%
Antioxidant
50%
Clinical Safety
50%
Anti-inflammatory Activity
50%
Synergistic Inhibition
50%
Elevated Triglycerides
50%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
50%
Non-high-density Lipoprotein Cholesterol (non-HDL-C)
50%
Plasminogen Activator inhibitor-1 (PAI-1)
50%
Peroxynitrite
50%
Cholesterol HDL
50%
Older Female Patient
50%
Statin Therapy
50%
70 Years Old
50%
Fruit Extract
50%
Bergamot Juice
50%
Phyto-extracts
50%
Oxygen Radical Absorbance Capacity
50%
Medicine and Dentistry
In Vitro
100%
Clinical Trial
100%
Triacylglycerol
100%
Cardiometabolic Risk
100%
Antioxidant Capacity
100%
Phytochemical
100%
High Density Lipoprotein Cholesterol
66%
Dyslipidemia
66%
Hemoglobin A1c
66%
Adverse Event
33%
Low Density Lipoprotein Cholesterol
33%
Statin
33%
Myeloperoxidase
33%
Post-Hoc Analysis
33%
Antioxidant
33%
Oxygen Radical
33%
Homeostatic Model Assessment
33%
Antiinflammatory Activity
33%
Apolipoprotein B
33%
Peroxynitrite
33%
Citrus Fruit Extract
33%
Plasminogen Activator Inhibitor-1
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Triacylglycerol
100%
Phytochemical
100%
Antioxidant Capacity
100%
Citrus
100%
Dyslipidemia
66%
Hemoglobin A1c
66%
High Density Lipoprotein Cholesterol
66%
Adverse Event
33%
Antioxidant
33%
Oxygen Radical
33%
Anti-Inflammatory Drug
33%
Myeloperoxidase
33%
Statin (Protein)
33%
Low Density Lipoprotein Cholesterol
33%
Peroxynitrite
33%
Apolipoprotein B
33%
Citrus Fruit Extract
33%
Nursing and Health Professions
Triacylglycerol
100%
Antioxidant
100%
Phytochemical
100%
High Density Lipoprotein Cholesterol
66%
Dyslipidemia
66%
Hemoglobin A1c
66%
Body Mass
33%
Adverse Event
33%
Low Density Lipoprotein Cholesterol
33%
Cholesterol Blood Level
33%
Post Hoc Analysis
33%
Female Patient
33%
Homeostasis Model Assessment
33%
Statins therapy
33%
Apolipoprotein B
33%
Myeloperoxidase
33%
Citrus Fruit Extract
33%
Oxygen Radical
33%
Peroxynitrite
33%
Efficacy
33%
Immunology and Microbiology
Citrus
100%
Antioxidant Activity
100%
In Vitro
100%
Cholesterol Blood Level
50%
Body Mass
50%
Antiinflammatory Activity
50%
Citrus Fruit Extract
50%
Myeloperoxidase
50%
Apolipoprotein B
50%